The difference of the effect of ARB on blood pressure and CARDIac functiOn in patients with essential hypertension
Phase of Trial: Phase I
Latest Information Update: 27 Jul 2015
Price : $35 *
At a glance
- Drugs Azilsartan (Primary) ; Olmesartan medoxomil (Primary)
- Indications Essential hypertension
- Focus Pharmacodynamics
- Acronyms CARDIO
- 27 Jul 2015 Status changed from not yet recruiting to completed as per University Hospital Medical Information Network - Japan.
- 25 Jul 2014 Planned number of patients changed from 60 to 30 as reported by University Hospital Medical Information Network - Japan.
- 01 Feb 2013 New trial record